You are here: MEDICA Portal. MEDICA Magazine. Archive.
Infectious Disease. Early HIV Treatment Increases Survival in
Patients with Tuberculosis Cambodian study demonstrates that
starting antiretroviral treatment two weeks, not two months,
after TB treatment increases survival 33 per cent; ©
panthermedia.net/Christine Müller The study's results – reported
by Doctor Anne Goldfeld of the Children's Hospital Boston and
the CAMELIA (Cambodian Early versus Late Introduction of
Antiretrovirals) study team – definitively show that
immunosuppressed HIV-TB co-infected patients should be started
on ART rapidly at two weeks after beginning TB therapy. At the
same time, the results strongly suggest that the World Health
Organisation (WHO) should be more aggressive in its
recommendations for treating such patients. A collaboration of
Cambodian, French, and American physicians and researchers, the
CAMELIA trial set out to settle a long-standing debate in the
medical community over the relative timing of antiretroviral
(ART)